CIBC Private Wealth Group’s AbbVie ABBV Stock Holding History

CIBC Private Wealth Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$267M	Sell	1,168,845 -10,906	-0.9%	-$2.48M	0.45%	59
2025 Q3	$273M	Buy	1,179,751 +13,087	+1%	+$2.67M	0.47%	58
2025 Q2	$217M	Buy	1,166,664 +142,700	+14%	+$26.5M	0.39%	75
2025 Q1	$180M	Sell	1,023,964 -30,139	-3%	-$5.86M	0.38%	72
2024 Q4	$188M	Sell	1,054,103 -23,714	-2%	-$4.36M	0.34%	81
2024 Q3	$213M	Buy	1,077,817 +254,972	+31%	+$47.6M	0.38%	74
2024 Q2	$137M	Sell	822,845 -7,520	-0.9%	-$1.25M	0.26%	99
2024 Q1	$150M	Sell	830,365 -8,862	-1%	-$1.53M	0.29%	92
2023 Q4	$130M	Buy	839,227 +115	+0%	+$16.8K	0.28%	94
2023 Q3	$125M	Sell	839,112 -65,170	-7%	-$9.57M	0.3%	86
2023 Q2	$122M	Buy	904,282 +21,135	+2%	+$3.1M	0.27%	95
2023 Q1	$141M	Sell	883,147 -18,979	-2%	-$2.9M	0.31%	78
2022 Q4	$71.7M	Buy	902,126 +70,964	+9%	+$10.9M	0.24%	79
2022 Q3	$112M	Buy	831,162 +11,992	+1%	+$1.72M	0.3%	80
2022 Q2	$125M	Buy	819,170 +45,038	+6%	+$6.88M	0.33%	78
2022 Q1	$125M	Sell	774,132 -18,366	-2%	-$2.67M	0.27%	91
2021 Q4	$107M	Buy	792,498 +72,506	+10%	+$8.56M	0.22%	105
2021 Q3	$77.7M	Sell	719,992 -51,545	-7%	-$5.89M	0.18%	116
2021 Q2	$86.9M	Buy	771,537 +709	+0.1%	+$79.8K	0.2%	115
2021 Q1	$83.4M	Sell	770,828 -316,875	-29%	-$33.9M	0.21%	113
2020 Q4	$117M	Sell	1,087,703 -8,776	-0.8%	-$843K	0.31%	82
2020 Q3	$96.5M	Buy	1,096,479 +648,886	+145%	+$61.1M	0.3%	81
2020 Q2	$43.9M	Sell	447,593 -45,844	-9%	-$4.04M	0.21%	90
2020 Q1	$37.6M	Buy	493,437 +10,990	+2%	+$936K	0.16%	125
2019 Q4	$42.7M	Sell	482,447 -33,569	-7%	-$2.79M	0.14%	137
2019 Q3	$39.1M	Sell	516,016 -11,267	-2%	-$772K	0.14%	139
2019 Q2	$38.3M	Sell	527,283 -30,135	-5%	-$2.37M	0.13%	152
2019 Q1	$44.9M	Sell	557,418 -16,733	-3%	-$1.37M	0.17%	137
2018 Q4	$52.9M	Sell	574,151 -33,306	-5%	-$2.93M	0.24%	118
2018 Q3	$57.5M	Sell	607,457 -31,088	-5%	-$2.95M	0.22%	121
2018 Q2	$59.2M	Sell	638,545 -94,422	-13%	-$9.22M	0.24%	117
2018 Q1	$69.4M	Sell	732,967 -190,956	-21%	-$21M	0.3%	103
2017 Q4	$89.4M	Sell	923,923 -92,172	-9%	-$8.69M	0.38%	82
2017 Q3	$90.3M	Sell	1,016,095 -191,847	-16%	-$14.6M	0.41%	71
2017 Q2	$87.6M	Sell	1,207,942 -253,134	-17%	-$17M	0.55%	61
2017 Q1	$95.2M	Buy	1,461,076 +1,107,729	+313%	+$69.6M	0.6%	56
2016 Q4	$22.1M	Sell	353,347 -1,988	-0.6%	-$121K	0.15%	126
2016 Q3	$22.4M	Sell	355,335 -4,448	-1%	-$288K	0.16%	124
2016 Q2	$22.3M	Sell	359,783 -936	-0.3%	-$57K	0.16%	121
2016 Q1	$20.6M	Buy	360,719 +10,931	+3%	+$609K	0.16%	127
2015 Q4	$20.7M	Buy	349,788 +4,087	+1%	+$235K	0.16%	128
2015 Q3	$18.8M	Sell	345,701 -16,670	-5%	-$1.09M	0.15%	127
2015 Q2	$24.3M	Sell	362,371 -21,389	-6%	-$1.4M	0.18%	115
2015 Q1	$22.5M	Sell	383,760 -4,583	-1%	-$277K	0.17%	120
2014 Q4	$25.4M	Sell	388,343 -1,550	-0.4%	-$97.7K	0.19%	113
2014 Q3	$22.5M	Sell	389,893 -3,402	-0.9%	-$189K	0.18%	117
2014 Q2	$22.2M	Buy	393,295 +8,960	+2%	+$470K	0.18%	119
2014 Q1	$20.5M	Buy	+384,335	New	+$19.4M	0.17%	125

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

CIBC Private Wealth Group's ABBV Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its AbbVie (ABBV) stake by 0.92% in Q4 2025, selling an estimated $2.48M and leaving 1,168,845 shares worth $267M. The position accounts for 0.45% of the portfolio, ranked #59.

CIBC Private Wealth Group first reported a position in ABBV in Q1 2014 and has held it in 48 quarters since. The position peaked at $273M in Q3 2025. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

CIBC Private Wealth Group held 1,168,845 shares of AbbVie worth $267M as of Q4 2025.
CIBC Private Wealth Group sold 10,906 AbbVie shares in Q4 2025, an estimated $2.48M.
AbbVie made up 0.45% of CIBC Private Wealth Group's portfolio in Q4 2025, its #59 holding.
CIBC Private Wealth Group first reported a position in AbbVie in Q1 2014 and has held it in 48 quarters since.
CIBC Private Wealth Group's AbbVie position peaked at $273M in Q3 2025.
4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.